Picture of Prestige Consumer Healthcare logo

PBH — Prestige Consumer Healthcare News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Prestige Consumer Healthcare Inc reports results for the quarter ended in March - Earnings Summary

* Prestige Consumer Healthcare Inc  PBH.N  reported a
quarterly
adjusted loss of $4.83​​ per share for the quarter ended in
March. The mean expectation of seven analysts for the quarter
was for earnings of $1.04 per share.
    * Revenue rose 7.1% to $285.87 million from a year ago;
analysts
expected $279.00 million. 
    * Prestige Consumer Healthcare Inc's reported EPS for the
quarter
was a loss of $4.83​.
    * The mean earnings estimate of analysts had fallen by
about 1% in
the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Prestige Consumer Healthcare Inc shares had fallen by 2.2%
this
quarter and lost 2.2% so far this year.
    * The company reported a quarterly loss of $240.55 million.
    * Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $70.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
4 at 01:33 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      1.04           -4.83          Missed
 Dec. 31 2022      1.01           1.04           Beat
 Sep. 30 2022      1.00           1.02           Beat
 Jun. 30 2022      1.04           1.09           Beat

Recent news on Prestige Consumer Healthcare

See all news